APA

Salloum R. M., Jaskowiak N. T., Mauceri H. J., Seetharam S., Beckett M. A., Koons A. M., Hari D. M., Gupta V. K., Reimer C., Kalluri R., Posner M. C., Hellman S., Kufe D. W. & Weichselbaum R. R. (20010222). NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity. : Cancer research.

Chicago

Salloum R M, Jaskowiak N T, Mauceri H J, Seetharam S, Beckett M A, Koons A M, Hari D M, Gupta V K, Reimer C, Kalluri R, Posner M C, Hellman S, Kufe D W and Weichselbaum R R. 20010222. NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity. : Cancer research.

Harvard

Salloum R. M., Jaskowiak N. T., Mauceri H. J., Seetharam S., Beckett M. A., Koons A. M., Hari D. M., Gupta V. K., Reimer C., Kalluri R., Posner M. C., Hellman S., Kufe D. W. and Weichselbaum R. R. (20010222). NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity. : Cancer research.

MLA

Salloum R M, Jaskowiak N T, Mauceri H J, Seetharam S, Beckett M A, Koons A M, Hari D M, Gupta V K, Reimer C, Kalluri R, Posner M C, Hellman S, Kufe D W and Weichselbaum R R. NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity. : Cancer research. 20010222.